c-Mpl and TPO expression in the human central nervous system neurons inhibits neuronal apoptosis
Author(s) -
Liang Li,
Chenju Yi,
Wenjie Xia,
Bihui Huang,
Shichao Chen,
Junyan Zhong,
Xiaoyi Fang,
Liuming Yang,
Hong-Wu Xin,
Shiying Silvia Zheng,
Beng H. Chong,
Yongshui Fu,
Chun Chen,
Mo Yang
Publication year - 2020
Publication title -
aging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 90
ISSN - 1945-4589
DOI - 10.18632/aging.103086
Subject(s) - neuroprotection , thrombopoietin , central nervous system , pi3k/akt/mtor pathway , apoptosis , signal transduction , biology , protein kinase b , microbiology and biotechnology , neuroscience , endocrinology , biochemistry , stem cell , haematopoiesis
Thrombopoietin (TPO) is a growth factor for the megakaryocytic/platelet lineage. In this study, we investigated the expression of TPO and its receptor, c-Mpl, in the human central nervous system (CNS) and their roles after a neural insult. Our results demonstrate that both TPO and c-Mpl are expressed in the neurons of the human CNS. TPO was also detected in human cerebrospinal fluid. TPO was found to be neuroprotective in hypoxic-ischemic neonatal rat brain models. In these rat models, treatment with TPO reduced brain damage and improved sensorimotor functions. In addition, TPO promoted C17.2 cell proliferation through activation of the PI3K/Akt signaling pathway. Via the Bcl-2/BAX signaling pathway, TPO exerted an antiapoptotic effect by suppressing mitochondrial membrane potentials. Taken together, our results indicate that TPO is neuroprotective in the CNS.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom